Europe

Active Indefinite Delivery Contract Awarded Last action

Contract number
SPE2DR25D9381
Awardee
Awarding agency
Task orders
11 $5,292 obligated

Award facts

Opportunity
Combined order value
$5,292 Current and potential, with all options
Last date to order 8% complete
IDV ceiling <1% used
$4,999,999.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Logistics Agency awarded a single-award indefinite-delivery contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on November 13, 2025, with a $4,999,999 ceiling and ultimate completion date of December 31, 2036.

Performance encompasses worldwide pharmaceutical distribution to Department of Defense military healthcare facilities. The contract authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's product portfolio spans oncology treatments, immunosuppressants, emergency medications, specialty surgical products, contraceptive devices, and routine pharmaceuticals.

The IDC derives from the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation posted February 1, 2024, which established a $30.3 billion estimated total acquisition value across multiple regional prime vendor contracts. The pre-solicitation indicated awards would be made on a regional basis with multiple contractors selected across North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. This contract carries a 30-month base period with three 30-month option periods. NAICS code 424210 and PSC code 6515 apply. The contract carries no set-aside designation.

Task orders

Task order Ordering agency Obligated Awarded
Hetastarch 6%-0.9% nacl bag 500ML SPE2DR26FGHY0 Defense Logistics Agency $186
Levetiracetam 500 MG/5 ML vial 5ML SPE2DR26FGHW6 Defense Logistics Agency $120
Midazolam HCL 50 MG/10 ML vial 10ML SPE2DR26FGHW4 Defense Logistics Agency $78
Silvadene 1% cream 20GM SPE2DR26FGHX7 Defense Logistics Agency $124
Thrombin-JMI 5,000 units vials SPE2DR26FGHX3 Defense Logistics Agency $2,696
Lidocaine HCL 1% syringe 5ML SPE2DR26FGHW9 Defense Logistics Agency $752
Levetiracetam 500 MG/5 ML vial 5ML SPE2DR26FGHW8 Defense Logistics Agency $120
Ciprofloxacin HCL 500 MG tab 100S SPE2DR26FGHX6 Defense Logistics Agency $336
Lidocaine HCL 1% syringe 5ML SPE2DR26FGHX5 Defense Logistics Agency $193
Mintox plus tablet chewable 100S SPE2DR26FGHW7 Defense Logistics Agency $15
Ciprofloxacin HCL 500 MG tab 100S SPE2DR26FGHX4 Defense Logistics Agency $672
Show all 11

Quick answers

Who was awarded contract SPE2DR25D9381?

SPE2DR25D9381 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.

How much is contract SPE2DR25D9381 worth?

Orders under SPE2DR25D9381 have obligated $5,292. SPE2DR25D9381's own ceiling is $4,999,999.

How many orders have been placed under contract SPE2DR25D9381?

11 orders have been placed under SPE2DR25D9381, the latest on April 28, 2026.

Who can order from contract SPE2DR25D9381?

SPE2DR25D9381 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract SPE2DR25D9381 competed?

The extent of competition for SPE2DR25D9381 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV